Selectively infective phage (SIP) technology: scope and limitations.
about
Recombinant antibodies: a novel approach to cancer diagnosis and therapy.Display technologies: application for the discovery of drug and gene delivery agents.Design of synthetic antibody libraries.Libraries against libraries for combinatorial selection of replicating antigen-antibody pairsCompartmentalized linkage of genes encoding interacting protein pairs.Use of periplasmic target protein capture for phage display engineering of tight-binding protein-protein interactions.
P2860
Selectively infective phage (SIP) technology: scope and limitations.
description
1999 nî lūn-bûn
@nan
1999 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Selectively infective phage (SIP) technology: scope and limitations.
@ast
Selectively infective phage (SIP) technology: scope and limitations.
@en
type
label
Selectively infective phage (SIP) technology: scope and limitations.
@ast
Selectively infective phage (SIP) technology: scope and limitations.
@en
prefLabel
Selectively infective phage (SIP) technology: scope and limitations.
@ast
Selectively infective phage (SIP) technology: scope and limitations.
@en
P2093
P1476
Selectively infective phage (SIP) technology: scope and limitations
@en
P2093
P304
P356
10.1016/S0022-1759(99)00143-X
P577
1999-12-01T00:00:00Z